Insider · CIK 0001239594
Peter M Castleman
director
Files at CAI (Caris Life Sciences, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 27, 2025 | CAI Caris Life Sciences, Inc. | AGrant or award Common Stock | +16,129 | $0.00 | $0 | 16,129 | Jun 23, 2025 |
| Jun 20, 2025 | CAI Caris Life Sciences, Inc. | CConversion Common Stockindirect: By CLS-PF-SPE, LLC | +10,245,906 | $0.00 | $0 | 10,270,906 | Jun 23, 2025 |
| Feb 27, 2025 | CAI Caris Life Sciences, Inc. | AGrant or award Stock Optionderivative | +2,500 | $0.00 | $0 | 2,500 | Jun 23, 2025 |
| Jun 20, 2025 | CAI Caris Life Sciences, Inc. | CConversion Series A Preferred Stockderivativeindirect: By CLS-PF-SPE, LLC | -40,983,607 | - | - | 0 | Jun 23, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.